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The new multimodality cardiovascular imaging journal, EuropeanHeart Journal – Cardiovascular Imaging, was created in 2012. Here, we summarize
the most important studies from the journal’s second year in two articles. Part I of the review will focus on studies in myocardial function, myo-
cardial ischaemia, and emerging techniques in cardiovascular imaging, and Part II will focus on valvular heart diseases, heart failure, cardiomyop-
athies, and congenital heart diseases.
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Introduction
The multimodality European Heart Journal – Cardiovascular Imaging has
successfully transitioned from an exclusive echocardiographic journal
2 years ago. The journal now serves as an important resource for
general cardiologists, specialists in all imaging modalities, and other
physiciansworking in thefieldofcardiovascular imaging. In twoarticles,
we highlight the most important studies that were published in the
journal in2013. Part I is focusedonstudies inmyocardial function,myo-




In addition to publishing original scientific studies, another important
assignment for European Heart Journal – Cardiovascular Imaging is to
publish position papers, recommendations and expert consensus
papers from the European Association of Cardiovascular Imaging
(EACVI). In 2013, the EACVI published three recommendations on
echocardiographic topics1– 3 and one expert consensus in the field
of multimodality imaging.4
Myocardial function
During the last few years, it has been apparent that assessment of
myocardial deformation by speckle-tracking echocardiography
adds important information to functional assessment by ejection
fraction (EF) only.5– 7 Knowledge of myocardial function is pivotal
in the diagnosis and risk stratification of patients with decreased myo-
cardial function.8 The most powerful method is left ventricular (LV)
global longitudinal strain (GLS) by two-dimensional (2D) speckle-
tracking strain. This was further confirmed in a prospective study of
425 patients referred for cardiac surgery.9 This study demonstrated
thatGLSwasan independentpredictor, superior toEF, forearly post-
operative mortality after adjustment to EuroSCORE.
In an era of multimodality imaging, it is important to know how
values compare between imaging modalities. A study by Puntmann
et al.10 compared cardiovascular magnetic resonance (CMR) with
transthoracic echocardiography (TTE) derived measurements of
LV chamber dimensions and wall thickness. In 101 subjects, including
33 patients with dilated LV, good agreement between CMR and TTE,
with a three-chamber CMR approach agreeing best with TTE.
Knowledge of myocardial function in cancer survivors after anthra-
cycline treatment is important. A study from Yu et al.11 showed that
children had impaired subendocardial circumferential deformation
and apical rotation with consequential reduction of transmural cir-
cumferential strain and rotation gradients.
Current strain technology by different vendors is not compliant
and different absolute strain values have been reported when com-
paring equipment from two or more vendors. It seems, however,
that longitudinal strain is very reproducible, while other deformation
directions show poorer reproducibility data. Therefore, the EACVI
initiated a standardized approach to deformation imaging jointly
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with the American Society of Echocardiography (ASE).12 The leaders
of the EACVI and the ASE invited representatives from all vendors to
participate in a concerted effort to reduce intervendor variability of
strain measurement. The experience of the committee so far has
demonstrated the potential for co-operation among vendors and
the imaging societies. The first report will be published during 2014
in our journal. A recent comparison between 3D strain from two dif-
ferent vendors showed that the agreement was poor except for lon-
gitudinal strain assessment13 and confirmed the need for a
standardization process.
Echocardiographic machines and software are constantly improv-
ing in regard to image quality, spatial resolution, and more. These
improvements might lead to slightly different measurements. It will
therefore be important to check normal ranges with newer equip-
ment and software. The aim of the Normal Reference Ranges for
Echocardiography Study (NORRE Study) is to obtain a set of
‘normal values’ for cardiac chamber geometry and function in a
large cohort of healthy Caucasian individuals (25–75 years) using
both conventional and advanced echocardiographic techniques.14
The first results were published in the journal in the beginning of
2014.15 The NORRE Study was performed in 22 laboratories accre-
dited by the EACVI and in one laboratory in the USA accredited by
Intersocietal Commission for the Accreditation of Echocardiography
Laboratories. The final sample sizewas 734 normal subjects, in whom
M-mode, 2D, and 3D imaging, colour Doppler, pulsed-wave
Doppler, pulsed-wave tissue Doppler, and colour tissue Doppler
imaging data were assessed. All studies were analysed in a central
echocardiographic core laboratory for quantitative analysis. The
first article presented a comprehensive analysis of chamber quantifi-
cation in the large NORRE cohort. Another study provides norma-
tive values for right atrial volumes and function measured by 3D
and 2D speckle-tracking echocardiography.16 Assessment of left
atrial (LA) mechanical function using speckle-tracking echocardiog-
raphy was found to be a valid approach and clinically feasible com-
pared with transoesophageal echocardiography.17
Assessment and interpretation of diastolic function remain diffi-
cult. The introduction of e′ was launched as a solution to many of
these problems, but controversies about its value persist. The
value of e′/a′ is not yet determined, but an important contribution
to a better knowledge on how to use this ratio was proposed by
Kim et al.18 They studied determinants of preserved diastolic function
at the lateral annulus in in 1166 consecutive patients with isolated
diastolic dysfunction. They found that patients with lateral e′/a′ . 1
were younger, male, and had a lower prevalence of diabetes and
hypertension and showed less evidence of LV diastolic dysfunction
and structural remodelling as LV hypertrophy and LA enlargement,
than those with a lateral e′/a′ , 1. It is also controversial whether
septal or lateral e′ should be the preferred measurement. Galderisi
et al.19 showed that the lateral e′ was the most accurate parameter
to predict increased LV filling pressure in patients with coronary
artery disease (CAD).
The complicated structure of the right ventricle (RV) makes it dif-
ficult to image with echocardiography. It consists of an inflow part in-
cluding the tricuspid valve apparatus; a trabecular part that includes
pronounced trabeculations; and an outflow tract consisting of a mus-
cular infundibulum, separating the tricuspid from the pulmonary
valve.20
The evaluation of the RV function has a very significant role as a
prognostic factor in patients with myocardial infarction (MI). Three-
dimensional echocardiography may offer benefits for RV assessment
than 2D echocardiography. In a recent study of 85 patients with RV
infarct and also with inferior myocardial infarct,21 the use of RV s′
as a parameter of RV performance was of similar value to discover
RV MI as the use of 3D echocardiography.
Knowledge of RVand atrial function is also important in pulmonary
hypertension. In a porcine model of RV chronic pressure overload,
Guihaire et al.22 found that non-invasive indices of RV function are
markers of ventricular–arterial coupling rather than ventricular con-
tractility. The widely used RV fractional areachange, tricuspid annular
plane systolic excursion, peak systolic tricuspid annular velocity (s)′,
and the RV myocardial performance index were all found to better
correlate to ventricular–arterial coupling as assessed by RV end-
systolic elastance/pulmonary arterial elastance.
Ischaemic heart disease
The mortality from atherosclerotic cardiovascular diseases (CVDs)
is steadily decreasing in many countries in Western Europe. CVD
remains, however, the major cause of death worldwide.23 This
patient group is also the largest group undergoing cardiac imaging
procedures in Europe. Traditional risk scores have many limitations
and are less accurate in subgroups as diabetics, women, younger
patients, and elderly subjects. The role of cardiovascular imaging in
detecting subclinical atherosclerosis is increasing and detection of
de facto initial disease might overcome some limitations of conven-
tional risk stratification.
CMR has an expanding range of indications and clinical applica-
tions.24 It is particularly useful for in vivo imaging of MI with
methods available for delineation of myocardial oedema, necrosis/
fibrosis, and ischaemia. In an ex vivo pig model of acute MI, Ubachs
et al. validated T2-weighted CMR for the quantification of myocar-
dium at risk against single-photon emission computed tomography
(SPECT) and infarct size against a histological reference standard.
The study showed that CMR accurately determined area at risk,
infarct size, and the derived measure of myocardial salvage.25
Several studies published in 2013 confirmed the prognostic value
of CMR in risk stratification after acute MI. In 309 patients, 3-month
infarct size ≥ median by late gadolinium enhancement (LGE) CMR
was a strong and independent predictor of outcome with an adjusted
hazard ratio of 1.13 per 1% increase.26 In a second study of 199
patients with acute ST elevation (STE) MI, CMR measures on LA
function were independently associated with the outcome.27
Other studies highlighted the value of combined low-dose dobu-
tamine and LGE CMR in the prediction of remodelling,28 which
was also the topic of a meta-analysis,29 and the infarct border zone
by LGE in the prediction of hard clinical endpoints.30 Other CMR
outcome measures were reviewed in the European Heart Journal –
Cardiovascular Imaging by Mavrogeni et al.31
Assessment and quantification of myocardial blood flow (MBF) by
CMR is increasingly used in clinical practice and now enshrined in
European guidelines. Ebersberger et al. evaluated perfusion CMR at
3 T in 116patients with suspectedor knownCADagainst the invasive
reference standard of pressure-wire-derived fractional flow reserve
(FFR). CMR had a sensitivity, specificity, and positive and negative
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predictive values at the patient level of 85, 87, 77, and 92%, respect-
ively.32 In an accompanying editorial, Plein and Motwani discussed the
appropriateness of using FFR as an endpoint for non-invasive imaging
studies, pointing out that FFR was initially validated against non-
invasive imaging. The authors propose that validated imaging tests
such as positron emission tomography may be more appropriate
endpoints for such studies.33
The use of regional GLS by echocardiography in patients with MI
has been extensively studied. The superiority of these parameters
to wall motion score index and EF in patients with acute STE MI
and relatively preserved LV function was recently demonstrated by
Cimino et al.34
Recent echocardiographic machines have the ability to assess de-
formation parameters from the different myocardial layers. However,
the techniques differ between vendors and their clinical value is not
established. A study comparing strain-encoded (SENC) CMR and 2D
speckle-tracking echocardiography demonstrates that both methods
can discriminate between different transmurality categories of MI
with similar accuracy.35 An experimental study could not show super-
iority of multilayer analyses in the assessment of reperfusion.36
Coronary flow reserve (CFR) assessment by transthoracic ultra-
sound of the left anterior descending (LAD) artery during dipyrid-
amole stress echocardiography has extensively been studied. In a
further study, CFR could predict adverse events when added to
standard evaluation in patients with acute coronary syndrome
(ACS) even in the absence of LAD disease.37
Intravascular ultrasound (IVUS) is not routinely in use in most of
the patient groups, but has an important role in research. Culprit
lesion-positive arterial remodelling by IVUS was associated with a
poor long-term prognosis in patients with ACS.38 This technique
may be a clinically useful marker of vulnerable patients.
The use of mitral annular plane systolic excursion measurement is
still helpful to evaluate LV systolic function in the case of poor sono-
graphic windows.39
It has been commonly believed that reduced myocardial flow
reserve (MFR) as a sign of early coronary dysfunction is linked with
the subsequent development of CAD. In a study by Uusitalo et al.,40
coronary calcium score (CCS) was measured 11 years after measure-
ment of CFR in 77 healthy, lean, normotensive, non-smoking, and
non-diabetic men (mean age 35 years). Thirty-nine percent of subjects
had a CCS. 0, but none had clinical symptoms or evidence of
ischaemia in stress echocardiography. At baseline, the average CFR
was comparable in individuals with or without coronary calcium in
the follow-up study, suggesting that coronary reactivity does not
predict the presence of coronary calcification in asymptomatic men
with very low likelihood of CAD at least with 11 years of follow-up.
Farhad et al.41 investigated the added value of the quantitative MBF
and the MFR in predicting major adverse cardiovascular events in
patients with suspected myocardial ischaemia. MBF was quantitated
using 82Rb and positron emission tomography in 351 patients. During
a median follow-up of 624 days, 35 major adverse cardiac events
(MACEs) occurred. As expected, MACE rate was higher in patients
with ischaemia than those without, but the quantitative MBF had
independent prognostic power in addition to standard analysis. The
authors concluded that MBF quantification has an added value allow-
ing further risk stratification in patients with normal and abnormal
perfusion images.
Adenosine stress CT myocardial perfusion imaging could enable
the detection of haemodynamic significance of intermediate coron-
ary stenosis detected by CT coronary angiography (CTCA). An
experimental study demonstrated that dynamic dual source CT
can quantitatively measure MBF and identify regional reductions of
MBF during adenosine stress over a wide range of flow-limiting
coronary artery obstruction severities with a good correlation to
coronary blood flow obtained with intracoronary flow probe or
FFR measurements.42
The combined or hybrid imaging of myocardial perfusion is gaining
increasing interest and various combinations (CT + SPECT, CT +
PET, and CT + CMR) have been investigated. In a study by Schaap
et al.,43 hybrid SPECT and CT coronary angiography were evaluated
in 98 patients and the results of the hybrid approach were compared
with standalone SPECT and CTCA for the diagnosis of significant
CAD. Parallel to what has been shown earlier, the sensitivities of
SPECT and CT angiography were high (93 and 98%), but the specifi-
cities were lower (79 and 62%). Hybrid analysis of SPECT and
CT angiography improved the overall performance but especially
the specificity (95%) without losing sensitivity (96%). The authors
confirmed that the combination of anatomy and function improves
the performance of the diagnostic test.
Cardiac CT and CAD
CTCA is a useful tool for the detection and especially ruling out ob-
structive CAD in selected patients with stable angina pectoris. In a
retrospective cohort of 498 stable, symptomatic patients with a low-
intermediate probability of CAD referred for either CTCA or
exercise-stress test, a frontline diagnostic strategy using CT incurred
lower costs related to downstream diagnostic utilization, ambulatory
visits, and cardiovascular medication than exercise-stress test-based
strategy.44 Meta-analyses of randomized controlled trials showed
that CTCA can be effective and safe as the first imaging test to
exclude significant CAD also in low-to-intermediate risk patients
with acutechest pain in the emergencydepartment.However, down-
streamutilization of resources is still amatterofdebate sincedifferent
results in the use of subsequent invasive coronary angiographies and
revascularizations have been detected.45,46
Evaluation of coronary stents by CTCA remains challenging
because partial volume or blooming artefacts from the highly attenu-
ated stent struts cause problems for the delineation of the coronary
stent lumen. The study by Gebhard et al.47 suggested that adaptive
statistical iterative reconstruction may be useful in CTCA evaluation
of these patients by improving intra-stent luminal area, diameter visu-
alization, and image quality compared with the standard filtered back
projection reconstruction.
Myocardial bridging, i.e. intramyocardial course of a coronary
artery causing it to be covered by a bridge of myocardium, can be
detected by CTCA. Rubishtein et al.48 found a relatively high
(35%) prevalence of myocardial bridging among a cohort of 334
symptomatic patients referred for CCTA and no obstructive
CAD. However, there was no association between myocardial
bridging and increased risk for cardiovascular death or MI during
6 years of follow-up.
Cardiac CT has potential to improve cardiovascular risk assess-
ment over conventional risk factors of CAD by the detection of cor-
onary calcium and non-calcified plaque as reviewed by Mureddu
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et al.23 Obesity is associated with the presence of CAD, but the rela-
tionships between body mass index (BMI) and conventional risk
factors that often co-exist with obesity are complex. In a multi-ethnic,
asymptomatic population of 1212 young men, obesity was associated
with the presence of coronary artery calcium independently of the
conventional risk factors of CAD.49 Similarly, among 13 874 patients
without known CAD undergoing CTCA, individuals with increased
BMI had greater prevalence, extent, and severity of CAD that was
not fully explained by the presence of traditional risk factors.50 Fur-
thermore, a higher BMI was independently associated with increased
risk of MI during an average of 2.4-year follow-up. In a cohort of 1535
individuals without clinically manifested CAD, the presence of
chronic obstructive pulmonary disease in long-term smokers was
associated with that of subclinical CAD measured by CCS independ-
entlyof traditional cardiovascular risk factors.51 AlthoughCADisone
of the underlying mechanisms of atrial fibrillation, Den Uijl et al.52
found that in the CTCA prior to radiofrequency catheter ablation
for atrial fibrillation, obstructive CAD or the presence of coronary
atherosclerosis was not associated with a higher risk for atrial fibril-
lation recurrence after ablation.
Low-attenuation plaque has been widely investigated as a marker
for atherosclerotic plaque vulnerability. Comparison with histology
in explanted hearts showed that low-attenuation plaque in CTA can
be used as a marker for lipid core plaque, i.e. plaque with a large
lipid/necrotic core.53 However, the (semi)-automated plaque
assessment tools based on measurement of the area between the
inner and outer vessel walls are prone to errors if cross-sections




The miniaturization and improvements in technology have led to the
development of pocket-size imagingdevices (PSIDs)with good image
quality and excellent portability. PSIDs are now widely available, and
their potential role in a hospital environment has been investigated
but still remains undefined.54 One study demonstrated that PSID
can provide a valuable alternative to TTE in the presence of
focused clinical questions and can provide an efficient way of deliver-
ing a ward-based transthoracic echo service. Another study showed
that the use of PSID after only brief bedside training greatly improved
the clinical diagnosis of medical students and junior doctors, over and
above history, physical examination, and ECG findings.55 A third
study showed that PSID used by a trained cardiologist has good diag-
nostic accuracy in the emergency setting compared with a high-end
echocardiograph.56
Contrast echocardiography
Myocardial contrast echocardiography has many advantages and
allows better assessment of wall motion, LV opacification and in
many patients myocardial perfusion.57 One major disadvantage is
the price of the contrast agents. The use of contrast agents in the
UK is, however, limited to,4% of all transthoracic echocardiograph-
ic studies.58 Major barriers to the implementation of contrast use are
the absence of cardiac imaging specialists directly supervising echo-
cardiography departments and the training of sonographers to inde-
pendently administer contrast. A new area for contrast was
Figure 1: Images of VFM. Velocity vectors were identified without angle dependency (left panel). The left ventricle was divided into three seg-
ments: base, mid, and apex (right panel).59
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demonstrated by Rutz et al. They showed that contrast could assist in
detecting chronic heart transplant rejection, i.e. cardiac allograft vas-
culopathy.
New imaging techniques
There is growing interest for intracardiac flow visualization. Recently
developed vector flow mapping (VFM) enables evaluation of local
flow dynamics without angle dependency.59
Retarded apical kinetic energy fluid dynamics could be detected
using VFM and were shown to be closely associated with LV spherical
remodelling in patients with high LA pressure (Figure 1).
Optical coherence tomography (OCT) is a recently developed
intravascular imaging modality that allows detailed assessment of
atherosclerotic plaque morphology, coronary stents, and abnormal
tissue reactions associated with stent implantation. Kawamori
et al.60 found that most cases of stent malapposition with a short
distance between the strut andvessel wall, thrombus, tissueprolapse,
or minor stent edge dissection improved during the 8-month follow-
up. Park et al.61 found that the presence of intra-stent thrombi was
seen as often in patients with or without aspirin/clopidogrel resist-
ance 195 days after implantation of a drug-eluting stent. A study of
Habara et al.62 revealed that the OCT morphological characteristics
of drug-eluting stent restenotic tissue varied depending on time after
stent implantation. Heterogeneous appearance of intima, thin-cap
fibroatheroma-like pattern image, and intra-intimal microvessels
were increased from the early (,1 year) to the very late (.3
years) phase. Matsuo et al.63 found that circulating levels of
malondialdehyde-modified low-density lipoprotein, which is an
oxidized low-density lipoprotein, were associated with the presence
of thin-cap fibroatheroma plaque morphology in OCT in patients
with either stable angina pectoris or ACS.
Conclusion
This review has summarized the studies in myocardial function, myo-
cardial ischaemia, and emerging techniques published in 2013 in the
European Heart Journal – Cardiovascular Imaging. Part II of the review
will focus on valvular heart diseases, heart failure, cardiomyopathies,
and congenital heart diseases.
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